Relyvrio

Amylyx’s ALS drug Relyvrio generates $71.4M in Q1
Amylyx’s ALS drug Relyvrio generates $71.4M in Q1
Medical Marketing and Media
Amylyx Pharmaceuticals
ALS
earnings
Relyvrio
Flag link:
Amylyx’s ALS drug sales impress Wall Street
Amylyx’s ALS drug sales impress Wall Street
BioPharma Dive
Amylyx
ALS
Relyvrio
Flag link:
Amylyx counters Wall Street noise, cites demand for ALS drug
Amylyx counters Wall Street noise, cites demand for ALS drug
Medical Marketing and Media
Amylyx Pharmaceuticals
Relyvrio
ALS
Flag link:
Cigna restricts coverage of new ALS drug, deepening fears about access
Cigna restricts coverage of new ALS drug, deepening fears about access
BioPharma Dive
Amylyx Pharmaceuticals
ALS
Relyvrio
insurers
Cigna
Flag link:
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
For ALS patients, doctors, a new medicine reignites concerns about healthcare access
BioPharma Dive
Amylyx
Relyvrio
ALS
patients
physicians
Flag link:
Days after Relyvrio’s FDA approval, Amylyx announces public offering to fund effort
Days after Relyvrio’s FDA approval, Amylyx announces public offering to fund effort
Medical Marketing and Media
Amylyx Pharmaceuticals
ALS
Relyvrio
stock offering
Flag link:
ALS drug's approval draws cheers from patients, questions from skeptics
ALS drug's approval draws cheers from patients, questions from skeptics
NPR
ALS
FDA
Amylyx Pharmaceuticals
drug pricing
Relyvrio
Flag link:
FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
Stat
Amylyx Pharmaceuticals
ALS
Relyvrio
FDA
Flag link: